Biotech CEO Sisterhood

BiotechTV

Ciencias Ciencias de la vida

Último episodio

26 episodios

Biotech CEO Sisterhood: Kate Haviland discusses the success factors that led to the $9B+ acquisition of Blueprint Medicines, and the trend of biotech companies taking commercial assets further
15/12/2025 | 36 min
Interviewed by Sisterhood editorial board member Daphne Zohar, Kate Haviland talks about the numerous programs that Blueprint created, the rationale behind key go/no-go and partnering decisions, and how she feels about the biotech sector today.
EpiBone creates bones and cartilage grown from stem cells - Co-Founder and CEO Nina Tandon describes the creative thinking she has used to accelerate its availability
11/12/2025 | 30 min
Interviewed by Sisterhood editorial board member Erika Smith, Nina Tandon describes what it has taken to get a startup through the recent difficult times for the biotech sector, including applying for military funding and making the product available in international markets where compassionate use is an option.
Biotech leader Sheila Gujrathi discusses her new book, The Mirror Effect, which she wrote for her younger self, today's peers, and the next generation of female leaders in business
02/12/2025 | 47 min
Interviewed by Sisterhood editorial board member Grace Colón, Dr. Gujrathi discusses a three pillar framework for success she has learned during her career in life sciences: know thyself, understand your environment, and set yourself up for success.
Stealth BioTherapeutics' CEO Reenie McCarthy describes the fortitude and close relationship with a patient community that led to the first approved therapy for Barth Syndrome
13/11/2025 | 21 min
Interviewed by Sisterhood editorial board member Erika Smith, Reenie McCarthy discusses how working with the Barth Syndrome Community, an ultra rare disease, helped the company better understand outcomes that are important to daily life for these patients. She also highlights the role that mitochondria play in biology, and the future of treatments for diseases of mitochondrial dysfunction.
Hanadie Yousef leads Juvena Therapeutics, a company developing protein based therapeutics that are tissue restorative for muscle and metabolic diseases
05/9/2025 | 11 min
She describes the process of how the company's computing platform sorts through proteins that are secreted by stem cells and screens them for therapeutic potential. Plus, the lead clinical program for muscle conditions and also a partnership with Lilly in the obesity space.

Más podcasts de Ciencias

Acerca de Biotech CEO Sisterhood

Members of the Biotech CEO Sisterhood regularly interview women leaders in biotech about news, science, management topics and more. Tune in to hear from top leaders in biotech about topics that matter to the industry.

Sitio web del podcast

Ciencias Ciencias de la vida